# The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation

> clinical trial · VERIFIED · 2026-01-02

Status: RECRUITING · Sponsor: MicroPort NeuroTech Co., Ltd. · Condition: Brain Arteriovenous Malformation

- Company: MicroPort NeuroTech Co., Ltd.
- Sector: neurointerventional
- Primary source: https://clinicaltrials.gov/study/NCT07314047

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.